PDT Partners’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,429
Closed -$915K 541
2018
Q4
$915K Sell
16,429
-47,747
-74% -$2.59M 0.05% 279
2018
Q3
$2.98M Sell
64,176
-21,424
-25% -$1.04M 0.12% 195
2018
Q2
$4.13M Sell
85,600
-712
-0.8% -$34.1K 0.16% 174
2018
Q1
$3.74M Sell
86,312
-19,194
-18% -$862K 0.13% 192
2017
Q4
$4.19M Buy
+105,506
New +$4.4M 0.12% 210
2015
Q4
Sell
-31,700
Closed -$2.08M 1152
2015
Q3
$2.08M Sell
31,700
-14,523
-31% -$964K 0.05% 426
2015
Q2
$3.13M Buy
+46,223
New +$2.55M 0.08% 301
2013
Q4
Sell
-13,230
Closed -$556K 1334
2013
Q3
$556K Sell
13,230
-796
-6% -$37.9K 0.02% 1006
2013
Q2
$632K Buy
+14,026
New +$550K 0.02% 981

PDT Partners's IMPV Position: Q1 2019 in Review

PDT Partners sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 16,429 shares — an estimated $915K sold.

PDT Partners first reported a position in IMPV in Q2 2013 and held it in 9 quarters. The position peaked at $4.19M in Q4 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • PDT Partners reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • PDT Partners sold 16,429 Imperva, Inc. shares in Q1 2019, an estimated $915K.
  • PDT Partners first reported a position in Imperva, Inc. in Q2 2013 and held it in 9 quarters.
  • PDT Partners's Imperva, Inc. position peaked at $4.19M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.